Related Experiment Video
Updated: Oct 30, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Differentially expressed proteins in platelets derived from patients with hypertension
Yobana Armenta-Medina1, Ivette Martínez-Vieyra1, Oscar Medina-Contreras2
1Laboratorio de Hematobiología, ENMyH, Instituto Politécnico Nacional, Mexico City, Mexico.
Platelets from hypertension patients show altered proteins impacting function. This study identified 11 key proteins involved in platelet activation, aggregation, and thrombus formation in hypertension.
Area of Science:
- Cardiovascular Biology
- Hematology
- Molecular Medicine
Background:
- Hypertension (HTN) is a global health issue causing end-organ damage and mortality.
- Blood cells, particularly platelets, are increasingly recognized for their role in HTN pathogenesis.
- Platelets from HTN patients exhibit altered membrane composition, affecting function and leading to vascular issues.
Purpose of the Study:
- To identify key proteins with differential expression in platelets from hypertension patients compared to normotensive individuals.
- To elucidate the molecular mechanisms underlying platelet dysfunction in hypertension.
Main Methods:
- Proteomic analysis was employed to compare protein expression profiles.
- Platelets were isolated from patients with hypertension and normotensive controls.
Main Results:
- Eleven proteins demonstrated the most significant expression differences in platelets from HTN patients.
- These proteins are implicated in cytoskeletal organization and the coagulation cascade.
- The identified proteins contribute to platelet activation, granule release, aggregation, and thrombus formation.
Conclusions:
- This study provides novel insights into the molecular basis of platelet involvement in hypertension.
- The identified proteins offer potential therapeutic targets for counteracting hypertension-associated cardiovascular complications.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

